Core Viewpoint - A securities class action lawsuit has been filed against Bitdeer Technologies Group for allegedly making false and misleading statements regarding its business operations and prospects during the class period from June 6, 2024, to November 10, 2025 [1][2]. Summary by Sections Allegations Against Defendants - The complaint claims that Bitdeer misrepresented its SEAL04 chip design progress, leading to production delays [2] - Bitdeer adopted a "dual-track approach" to create two independent designs to compensate for lost progress, while still assuring the public that production timelines were on track [2] - As a result, statements made by the defendants regarding the company's business and operations were materially false and misleading [2] Lead Plaintiff Process - Investors in Bitdeer can seek to be appointed as lead plaintiff by February 2, 2026, or may choose to remain absent from the class [3] - The lead plaintiff represents the interests of all class members and selects counsel to direct the litigation [3] Law Firm Background - Kessler Topaz Meltzer & Check, LLP is a prominent U.S. law firm specializing in securities-fraud class actions and investor protection [4] - The firm has a history of leading significant recoveries in securities litigation and has received multiple accolades for its work [4]

Core Insights - Varonis Systems, Inc. reported disappointing financial results for Q3 2025, with a significant 63.9% year-over-year decline in term license subscription revenues, leading to a reduction in full-year ARR guidance [2] - The company's on-premises subscription business has been identified as a major factor hindering overall ARR growth, attributed to lower renewal rates and sales process issues [2] - Following the announcement of these results, Varonis' stock price plummeted by $30.66, or 48.67%, closing at $32.34 per share on October 29, 2025 [2] Financial Performance - Varonis' Q3 2025 revenue missed consensus estimates, indicating potential challenges in meeting market expectations [2] - The decline in term license subscription revenues is a critical concern, reflecting broader issues within the company's subscription model [2] Company Response - Varonis acknowledged the underperformance of its on-prem subscription business and its impact on overall growth, highlighting the need for improvements in sales processes and renewal rates [2]

Core Viewpoint - The Freeport-McMoRan Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims related to safety issues at its Grasberg mine in Indonesia and subsequent operational impacts [1][3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Reed v. Freeport-McMoRan Inc., and it involves purchasers of Freeport-McMoRan securities from February 15, 2022, to September 24, 2025 [1]. - The lawsuit alleges that Freeport-McMoRan failed to ensure adequate safety measures at the Grasberg Block Cave mine, leading to heightened risks for workers [3]. - On September 9, 2025, Freeport-McMoRan reported a significant incident at the Grasberg mine, resulting in a nearly 6% drop in stock price [4]. Group 2: Incident Impact - Following the September 8 incident, Freeport-McMoRan disclosed that two team members were fatally injured, and production in 2026 could be approximately 35% lower than pre-incident estimates, causing a nearly 17% decline in stock price [5]. - An article published on September 25, 2025, highlighted potential strains in Freeport-McMoRan's relationship with the Indonesian government, leading to an additional stock price drop of over 6% [6]. Group 3: Legal Process - Investors who purchased Freeport-McMoRan securities during the class period can seek appointment as lead plaintiff, representing the interests of the class [7]. - The lead plaintiff will have the authority to select a law firm for litigation, but participation as lead plaintiff is not required for potential recovery [7]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Group 3: Financial Performance and Stock Impact - Alexandria Real Estate reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to a property in Long Island City, New York, citing lower occupancy rates and slower leasing activity [5][6].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. and its senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Eastern District of Virginia, titled MacMahon v. Stride, Inc., et al., No. 1:25-cv-02019 [3]. - Investors have until January 12, 2026, to request to lead the case, with claims made under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Allegations Against Stride - Stride, an education technology company, allegedly inflated enrollment numbers by retaining "ghost students" and ignored compliance requirements, leading to poor customer experiences and higher withdrawal rates [4]. - The company claimed to be experiencing growth and strong demand, which is contradicted by the allegations of inflated metrics and customer dissatisfaction [4]. Group 3: Stock Price Impact - Following the fraud allegations reported on September 14, 2025, Stride's stock dropped by $18.60, or over 11%, from $158.36 to $139.76 per share [5]. - On October 28, 2025, Stride acknowledged that poor customer experiences led to an estimated 10,000-15,000 fewer enrollments, resulting in a stock price decline of $83.48, or more than 54%, from $153.53 to $70.05 per share [6].

Core Viewpoint - A class action lawsuit has been filed against Freeport-McMoRan Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Arizona, captioned Reed v. Freeport-McMoRan Inc., et al., No. 2:25-cv-04243 [3]. - Investors have until January 12, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Freeport securities [3]. Group 2: Company Operations and Safety Claims - Freeport operates the Grasberg Copper and Gold Mine in Indonesia, where it has been accused of overstating its commitment to safety while conducting unsafe mining practices [4][5]. - The company had previously promoted its safety procedures, including the use of data and technology to prevent fatal incidents [4]. Group 3: Stock Price Impact - On September 9, 2025, Freeport's stock dropped by $2.77 per share (over 5.9%) following a press release about suspended mining operations due to a landslide [6]. - Following an update on September 24, 2025, regarding fatalities and operational suspensions, the stock fell by $7.69 per share (almost 17%) [7]. - A report on September 25, 2025, regarding strained relations with the Indonesian government led to an additional drop of $2.33 per share (over 6%) [8]. - An Indonesian news report on September 28, 2025, indicated that the landslide was preventable, further impacting investor sentiment [9].

Core Viewpoint - A lawsuit has been filed against MoonLake Immunotherapeutics and its senior executives for potential violations of federal securities laws, following disappointing results from clinical trials that raised questions about the company's drug's regulatory approval and commercial viability [1][2][5]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, captioned Peters v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08612 [2]. - Investors have until December 15, 2025, to request to be appointed to lead the case [2]. Group 2: Company Background - MoonLake is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases, specifically through its investigational therapeutic sonelokimab (SLK) [3]. - The company claimed that its "strong clinical data" from the Phase 2 MIRA trial indicated higher clinical responses and differentiation from competitors [4]. Group 3: Clinical Trial Results - The VELA Phase 3 trials for sonelokimab reported disappointing results, with VELA-2 failing to meet its primary endpoint, which raised concerns about the drug's chances for regulatory approval [6]. - Following the announcement of the trial results on September 28, 2025, MoonLake's stock price plummeted nearly 90%, from $61.99 per share to $6.24 per share [6].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is based on claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, representing investors in CarMax securities [3]. - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [3]. Group 2: Company Performance and Stock Impact - CarMax reported disappointing financial results for Q2 of fiscal year 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [6]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million the previous year, attributed to a "pull forward" in demand due to U.S. tariffs [6]. - Following the financial report, CarMax's stock price dropped by $11.45 per share, or roughly 20%, from $57.05 to $45.60 on September 25, 2025 [7]. - An unexpected departure of CEO Bill Nash on November 6, 2025, along with a weak preliminary Q3 outlook, led to an additional stock drop of over 24% [7]. Group 3: Company Background - CarMax operates in the used car sales industry and had previously promoted strong demand for its vehicles, which was later questioned due to the impact of tariffs [4]. - The law firm Bleichmar Fonti & Auld LLP, representing the plaintiffs, has a history of successful recoveries in securities class actions, including over $900 million from Tesla's Board of Directors [9].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - Synopsys, Inc. provides design automation software products used for designing and testing integrated circuits. Its Design IP segment, which supplies pre-designed silicon components to semiconductor companies, has been the fastest-growing segment, increasing from 25% of revenue in 2022 to 31% in 2024 [4]. Financial Performance - In Q3 2025, Synopsys reported a revenue of $425.9 million for its Design IP segment, reflecting a 7.7% year-over-year decline. The net income was $242.5 million, marking a 43% year-over-year decline [6]. Customer Dynamics - The lawsuit alleges that while Synopsys claimed its customers relied on its IP to minimize integration risk and speed time to market, the reality was that customers began requiring more customization for IP components, negatively impacting the economics of the Design IP business [5]. Stock Market Reaction - Following the release of disappointing Q3 2025 results, Synopsys's stock price fell from $604.37 per share to $387.78 per share, a decline of nearly 36% [6].

New York, New York--(Newsfile Corp. - December 14, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/i ...